Ascletis Pharmaceuticals Co., Ltd.

This early-phase study tested a new daily pill, ASC61, in 18 adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the right dose. ASC61 works by blocking a protein called PD-L1, which helps the…

This study looked at the long-term safety of a daily pill called ASC40 (Denifanstat) for people with moderate to severe acne. About 240 participants who finished a previous 12-week study took the drug for up to 40 weeks. Researchers tracked side effects and checked if acne improv…